Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.

Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.

Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Explore more from The Transmitter
Keeping it personal: How to preserve your voice when using AI
To harness the workmanlike prose of artificial intelligence while maintaining a recognizable style, use it as an analyzer rather than as a writer.

Keeping it personal: How to preserve your voice when using AI
To harness the workmanlike prose of artificial intelligence while maintaining a recognizable style, use it as an analyzer rather than as a writer.
Null and Noteworthy, relaunched: Probing a schizophrenia biomarker
This edition of Null and Noteworthy—the first for The Transmitter—highlights new findings about the auditory steady-state response in people with schizophrenia that, all within one study, somehow packed in a null result and a failed replication.

Null and Noteworthy, relaunched: Probing a schizophrenia biomarker
This edition of Null and Noteworthy—the first for The Transmitter—highlights new findings about the auditory steady-state response in people with schizophrenia that, all within one study, somehow packed in a null result and a failed replication.
Cell ‘fingerprints’ identify distinct cortical networks
These networks align with different assemblages of cells, a finding that could reveal how cellular diversity influences brain function, according to a new study.

Cell ‘fingerprints’ identify distinct cortical networks
These networks align with different assemblages of cells, a finding that could reveal how cellular diversity influences brain function, according to a new study.